Application of human chorionic gonadotropin in preparation of pregnancy assisting medicine for patients with premature ovarian insufficiency
A technology for chorionic gonadotropin and ovarian function, which can be used in drug combinations, sexual diseases, pharmaceutical formulations, etc., and can solve the problems of unclear etiology, uncertain treatment effect, and high cost of POI.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] A fertility aid drug for patients with premature ovarian insufficiency, the drug is composed of the following independently packaged preparations: progamma, medroxyprogesterone tablets and human chorionic gonadotropin.
Embodiment 2
[0032] Fu Mou, 31 years old, 0-0-0-0, has not been pregnant for 1 year without contraception. Since the age of 23, she began to have thin menstruation, with a menstrual cycle of 40 to 180 days, accompanied by symptoms such as hot flashes, insomnia, and dyspareunia. She has been interrupting hormone replacement therapy to maintain normal menstruation. On April 20, 2017, the endocrine test in the other hospital: FSH 95.65mIU / ml, E212 pg / ml, LH 29.75mIU / ml. After getting married in March 2018, I started to prepare for pregnancy. I took femotone orally every month to maintain menstruation, and B-ultrasound monitored follicles every week or every two weeks. B-ultrasound for 1 year showed that both ovaries were atrophic and there were no follicles.
[0033] First visit on June 11, 2019. B-ultrasound on the day of the first visit: the size of the uterus was 38*42*40mm, and the echo of the muscular layer was uniform; the left ovary was 12*7mm, the ovary was solid, and no follicles we...
Embodiment 3
[0036] Lu, 31 years old, 1-0-0-1, has not been pregnant for 7 years without contraception. The patient gave birth to a child with her current husband 7 years ago, and has not been pregnant since then without contraception. At the age of 26, the menstrual cycle was advanced, and the menstrual cycle was disordered in the past 2 years. He needed to withdraw progesterone and bleed. One year ago, he began to have hot flashes and insomnia symptoms, and he took femotone intermittently to maintain menstruation. No antral follicles were found in continuous B-ultrasound monitoring for 1 year. In April 2019, bFSH was 32.26mIU / ml; in July 2019, bFSH was 52.67mIU / ml; in April 2020, FSH was 64.83mIU / ml, and AMH was 0.01ng / ml.
[0037] First visit on May 15, 2020. The B-ultrasound on the day of the first visit revealed bilateral ovarian atrophy (Lov 12*9; Rov 12*10), with solid echoes and no follicles in both ovaries. Karyotype 46, XX. FSH 36.36mIU / ml, E2105 pg / ml, LH 22.23mIU / ml.
[00...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com